EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro

Yaser Gamallat iD, Huseen Alwazan iD, Rasoul Turko, Vincent Dang iD, Sima Seyedi iD, Sunita Ghosh iD, Tarek A Bismar iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yaser Gamallat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Cell Movement, Cell Proliferation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prostate Cancer Canada and The Canadian Cancer Society and proudly funded by the Canadian Cancer Society,, Prostate Cancer Foundation Young Investigator Award, Canadian Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Late endosomal/lysosomal adaptor, MAPK and mTOR, or LAMTOR, is a scaffold protein complex that senses nutrients and integrates growth factor signaling. The role of LAMTOR4 in tumorigenesis is still unknown. However, there is a considerable possibility that LAMTOR4 is directly involved in tumor cell proliferation and metastasis. In the current study, we investigated the protein expression of LAMTOR4 in a cohort of 314 men who were undergoing transurethral resection of prostate (TURP) consisting of incidental, advanced and castration-resistant cases. We also correlated the data with ERG and PTEN genomic status and clinicopathological features including Gleason score and patients’ outcome. Additionally, we performed in vitro experiments utilizing knockdown of LAMTOR4 in prostate cell lines, and we performed mRNA expression assessment using TCGA prostate adenocarcinoma (TCGA-PRAD) to explore the potential differentially expressed genes and pathways associated with LAMTOR4 overexpression in PCa patients. Our data indicate that high LAMTOR4 protein expression was significantly associated with poor overall survival (OS) (HR: 1.44, CI: 1.01–2.05, p = 0.047) and unfavorable cause-specific survival (CSS) (HR: 1.71, CI: 1.06–2.77, p = 0.028). Additionally, when high LAMTOR4 expression was combined with PTEN-negative cases (score 0), we found significantly poorer OS (HR: 2.22, CI: 1.37–3.59, p = 0.001) and CSS (HR: 3.46, CI: 1.86–6.46, p < 0.0001). Furthermore, ERG-positive cases with high LAMTOR4 exhibited lower OS (HR: 1.98, CI: 1.18–3.31, p = 0.01) and CSS (HR: 2.54, CI: 1.32–4.87, p = 0.005). In vitro assessment showed that knockdown of LAMTOR4 decreases PCa cell proliferation, migration, and invasion. Our data further showed that knockdown of LAMTOR4 in the LNCaP cell line significantly dysregulated the β catenin/mTOR pathway and tumorigenesis associated pathways. Inhibiting components of the mTOR pathway, including LAMTOR4, might offer a strategy to inhibit tumor progression and metastasis in prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingCell MovementCell ProliferationGene Expression Regulation, NeoplasticProstatic NeoplasmsAgedHumansMaleMiddle AgedCell Line, TumorGene Knockdown TechniquesNeoplasm InvasivenessPrognosisPTEN PhosphohydrolaseGuanine Nucleotide Exchange Factors

Stichwörter der Autor:innen

ERGMAPKPTENlate endosomal/lysosomal adaptormTOR activator 4 (LAMTOR4)mammalian target of rapamycin (mTOR)

Substanzen

Adaptor Proteins, Signal TransducingPTEN PhosphohydrolasePTEN protein, humanLAMTOR4 protein, humanGuanine Nucleotide Exchange Factors

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Departments of Oncology, Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Departments of Mathematical and Statistical Sciences and Medical Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R7, Canada.
  • Tom Baker Cancer Center, Alberta Health Services, Calgary, AB T2N 4N1, Canada.
  • Prostate Cancer Centre, Rockyview General Hospital, Calgary, AB T2V 1P9, Canada.

ORCID-Profile: Yaser Gamallat, Huseen Alwazan, Vincent Dang, Sima Seyedi, Sunita Ghosh, Tarek A Bismar

Förderung

  • Prostate Cancer Canada and The Canadian Cancer Society and proudly funded by the Canadian Cancer Society,
  • Prostate Cancer Foundation Young Investigator Award
  • Canadian Cancer Society

Zitieren

APA

Gamallat, Y., Alwazan, H., Turko, R., Dang, V., Seyedi, S., Ghosh, S., & Bismar, T. A. (2024). Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158100

Vancouver

Gamallat Y, Alwazan H, Turko R, Dang V, Seyedi S, Ghosh S, et al. Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158100

BibTeX
@article{Gamallat2024,
  author = {Gamallat, Yaser and Alwazan, Huseen and Turko, Rasoul and Dang, Vincent and Seyedi, Sima and Ghosh, Sunita and Bismar, Tarek A},
  title = {Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158100}
}
Kostenlos starten →